Nathalie Franchimont
Directeur Technique/Scientifique/R&D chez Nimbus Therapeutics LLC
Profil
Nathalie Franchimont is currently the Director at OMass Therapeutics Ltd.
since 2020 and the Chief Medical Officer at Nimbus Therapeutics LLC since 2022.
Previously, she worked at Biogen, Inc. as a Senior Vice President.
Postes actifs de Nathalie Franchimont
Sociétés | Poste | Début |
---|---|---|
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Directeur Technique/Scientifique/R&D | 26/10/2022 |
OMass Therapeutics Ltd.
OMass Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services OMass Therapeutics Ltd. develops native mass spectrometry platform The company was founded by Dame Carol Robinson and is headquartered in Oxford, the United Kingdom. | Directeur/Membre du Conseil | 01/01/2020 |
Anciens postes connus de Nathalie Franchimont
Sociétés | Poste | Fin |
---|---|---|
BIOGEN INC. | Corporate Officer/Principal | - |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
BIOGEN INC. | Health Technology |
Entreprise privées | 2 |
---|---|
Nimbus Therapeutics LLC
Nimbus Therapeutics LLC BiotechnologyHealth Technology Nimbus Therapeutics LLC provides drug discovery research services. It is a computational technology-driven paradigm to rapidly advance a diverse pipeline of novel small molecule product candidates into clinical development. The company was founded by Bruce Lee Booth in 2009 and is headquartered in Cambridge, MA. | Health Technology |
OMass Therapeutics Ltd.
OMass Therapeutics Ltd. Miscellaneous Commercial ServicesCommercial Services OMass Therapeutics Ltd. develops native mass spectrometry platform The company was founded by Dame Carol Robinson and is headquartered in Oxford, the United Kingdom. | Commercial Services |